John Higgins
Président chez OMNIAB, INC.
Fortune : 14 M $ au 30/04/2024
Postes actifs de John Higgins
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIO-TECHNE CORPORATION | Directeur/Membre du Conseil | 19/05/2009 | - |
Independent Dir/Board Member | 19/05/2009 | - | |
PFENEX INC. | Directeur/Membre du Conseil | 01/10/2020 | - |
OMNIAB, INC. | Président | 01/11/2022 | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Directeur Général | 01/01/2010 | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Président | - | - |
Directeur/Membre du Conseil | 01/12/2015 | 01/03/2022 | |
President | 01/12/2015 | 01/03/2022 | |
Academy of Whole Learning
Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Président | - | - |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Directeur Général | - | - |
Historique de carrière de John Higgins
Anciens postes connus de John Higgins
Sociétés | Poste | Début | Fin |
---|---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | 12/07/2011 | 31/12/2022 |
Directeur Général | 15/01/2007 | 05/12/2022 | |
President | 15/01/2007 | 27/01/2015 | |
BIOCRYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2004 | - |
Independent Dir/Board Member | 01/01/1994 | - | |
░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de John Higgins
Colgate University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 15 |
Opérationnelle
Director/Board Member | 6 |
Chairman | 4 |
Chief Executive Officer | 3 |
Sectorielle
Health Technology | 10 |
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
BIO-TECHNE CORPORATION | Health Technology |
OMNIAB, INC. | Commercial Services |
Entreprise privées | 9 |
---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Dillon, Read & Co., Inc. | Finance |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Blue Zones LLC
Blue Zones LLC Medical/Nursing ServicesHealth Services Blue Zones LLC provides healthcare services. The company was founded by Dan Buettner and is headquartered in Minneapolis, MN. | Health Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
Academy of Whole Learning
Academy of Whole Learning Miscellaneous Commercial ServicesCommercial Services Academy of Whole Learning provides a comprehensive educational experience for children with autism spectrum disorder and learning difficulties. The private company is based in Minnetonka, MN. | Commercial Services |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- John Higgins
- Expérience